Majid Mahmoodi , Saeid Rajabalian , A Foroumadi , Saeid Hidarykeshel , Malihe Sadat Safavi , A Khoshzaban , Korous Divsalar , Mohammad Ali Mohagheghi ,
Volume 67, Issue 6 (9-2009)
Abstract
Background: 4-Aryl-4H-chromenes are novel anticancer agents which induce apoptosis in cancer cells. These compounds were found to induce apoptosis by targeting the tubulin/microtubule system in cell proliferation process. The aim of this study was to report cyototoxic and apoptosis inducing activities of a new series of synthesized 4-aryl-4H-chromenes compounds.
Methods: The in vitro cytotoxic activity of the synthesized 4-aryl-4H-chromenes was investigated against a paned of human cancer cell lines including MCF-7 (breast carcinoma), A549 (lung carcinoma), HEPG-2 (liver carcinoma), SW-480 (colon adenocarcinoma), U87-MG (glioblastoma), 1321N1 (astrocytoma), and DAOY (medulloblastoma). The percentage of growth inhibitory activity was evaluated using MTT colorimetric assay versus controls not treated with test derivatives. The data for etoposide, a well known anticancer drug, was included for comparison. For each compound, the 50% inhibitory concentration (IC50) were determined. Apoptosis inducing activity were assessed by DAPI staining.
Results: Preliminary screening showed that those chromenes analogs bearing phenyl-isoxazole-3-yl substitution or the derivatives containing methoxyphenyl in chromene ring exhibited cytotoxic and apoptotic inducing activity comparable with or even superior than the reference drug, etoposide. The compounds without this type of substitution have lower activity.
Conclusions: Replacement of 3, 4, 5-trimethoxyphenyl group with thiazol ring in the synthesized derivatives reduced the cytotoxic activity. However, the derivatives with phenyl-isoxazole analogue showed potent cytotoxic and apoptotic inducing activity.
Soltan Dallal Mm, Nikkhahi F, Khirkhah A, Molaei S, Hosseyni Sk, Rastegar Lari A, Rahimi Foroushani A, Khoshzaban A, Kalafi Z,
Volume 69, Issue 10 (5 2012)
Abstract
Normal
0
false
false
false
EN-US
X-NONE
AR-SA
MicrosoftInternetExplorer4
Background: Human
amniotic membrane (HAM) forms the inner wall of the membranous sac that surrounds and
protects the embryo during gestation.
The main advantages of amniotic membrane transplantation (AMT) in the treatment of bacterial
keratitis are its epithelial bandage properties. Previous studies have
documented the presence of some antimicrobial proteins and peptides in amniotic
fluid such as lactoferrin, lysozyme, bactericidal or permeability increasing
protein, calprotectin (MRP8/14 protein complex), LL37, and neutrophil defensins (Human Neutrophil Peptides, HNP
1-3). Furthermore, the amniotic membrane does
not express HLA-A, B, C or DR surface antigens, which may help avoid rejection after its transplantation.
Thus, it can be used as a biological immune barrier. The purpose of this study was
to evaluate the effectiveness of the amniotic membrane's healing properties in
rabbits with pseudomonas keratitis.
Methods : By using an animal model, 14 rabbits were divided into two groups of controls and cases. A syringe was used to inoculate
the corneal stroma of the animals by Pseudomonas aeruginosa ATCC27853. After 20 hours
pseudomonas keratitis was created and amniotic membrane was transplanted to the
cornea of the case group. The infiltration size were observed on the first, third
and seventh days after the experiment.
Results : Corneal perforation was seen in the controls (P<0.001) but amniotic membrane
prevented perforation in the case group (P=0.02).
Conclusion: Transplantation of
amniotic membrane in the primary stages of pseudomonas keratitis treatment remarkably
prevents corneal perforation and it can be used to control the disease process.
